1. Home
  2. VTAK vs LICN Comparison

VTAK vs LICN Comparison

Compare VTAK & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTAK
  • LICN
  • Stock Information
  • Founded
  • VTAK 2002
  • LICN 2004
  • Country
  • VTAK United States
  • LICN China
  • Employees
  • VTAK N/A
  • LICN N/A
  • Industry
  • VTAK Medical/Dental Instruments
  • LICN
  • Sector
  • VTAK Health Care
  • LICN
  • Exchange
  • VTAK Nasdaq
  • LICN Nasdaq
  • Market Cap
  • VTAK 3.9M
  • LICN 3.1M
  • IPO Year
  • VTAK 2018
  • LICN 2023
  • Fundamental
  • Price
  • VTAK $3.04
  • LICN $4.49
  • Analyst Decision
  • VTAK
  • LICN
  • Analyst Count
  • VTAK 0
  • LICN 0
  • Target Price
  • VTAK N/A
  • LICN N/A
  • AVG Volume (30 Days)
  • VTAK 3.1M
  • LICN 163.7K
  • Earning Date
  • VTAK 08-11-2025
  • LICN 01-01-0001
  • Dividend Yield
  • VTAK N/A
  • LICN N/A
  • EPS Growth
  • VTAK N/A
  • LICN N/A
  • EPS
  • VTAK N/A
  • LICN N/A
  • Revenue
  • VTAK $600,000.00
  • LICN $41,477,000.00
  • Revenue This Year
  • VTAK $822.86
  • LICN N/A
  • Revenue Next Year
  • VTAK $168.42
  • LICN N/A
  • P/E Ratio
  • VTAK N/A
  • LICN N/A
  • Revenue Growth
  • VTAK 37.62
  • LICN 4.32
  • 52 Week Low
  • VTAK $2.49
  • LICN $2.60
  • 52 Week High
  • VTAK $43.70
  • LICN $462.00
  • Technical
  • Relative Strength Index (RSI)
  • VTAK 44.02
  • LICN 52.04
  • Support Level
  • VTAK $2.70
  • LICN $4.18
  • Resistance Level
  • VTAK $4.31
  • LICN $4.65
  • Average True Range (ATR)
  • VTAK 0.37
  • LICN 0.50
  • MACD
  • VTAK 0.03
  • LICN 0.02
  • Stochastic Oscillator
  • VTAK 30.22
  • LICN 44.03

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

Share on Social Networks: